GO:0070290 N-acylphosphatidylethanolamine-specific phospholipase D activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0070290 describes the enzymatic activity that converts N-acylphosphatidylethanolamine (NAPE) into N-acylethanolamine (NAE) plus phosphatidic acid, a key step in endocannabinoid-related lipid signaling.
• The enzyme is best known as NAPE-specific phospholipase D (NAPE-PLD), and its expression is strongly induced by proinflammatory stimuli in macrophages.
• NAPE-PLD activity is important in the endometrium and placenta, where it contributes to endocannabinoid tone and pregnancy-related processes.
• Dysregulated NAPE-PLD has been linked to endometrial carcinoma, making it a candidate biomarker and therapeutic target.
• The reaction is a phospholipase D-type hydrolysis that releases both an NAE and phosphatidic acid, linking lipid metabolism to signaling.
• CRISPR-based knockout, knock-in, point-mutation and overexpression models are powerful tools to dissect NAPE-PLD function in health and disease.
Description
GO:0070290, N-acylphosphatidylethanolamine-specific phospholipase D activity, is a molecular function that catalyzes the hydrolysis of N-acylphosphatidylethanolamine (NAPE) to produce an N-acylethanolamine (NAE) and phosphatidic acid. This activity is central to the endocannabinoid system because it generates bioactive NAE lipids, including anandamide, which modulate pain, inflammation, and reproductive processes. Researchers study this term to understand how lipid signaling is controlled at the membrane and how it contributes to physiology and disease. The enzyme responsible, NAPE-PLD, is expressed in immune cells, reproductive tissues, and adipose tissue, where its regulation affects local lipid mediator production. In macrophages, proinflammatory stimuli such as lipopolysaccharide increase NAPE-PLD expression, linking this activity to inflammatory responses. In the uterus and placenta, NAPE-PLD participates in endocannabinoid signaling that influences embryo implantation and pregnancy maintenance. Because of its roles in inflammation, reproduction, and cancer, GO:0070290 is a high-value target for functional genomics and therapeutic development.
N-acylphosphatidylethanolamine-specific phospholipase D activity At A Glance
| GO ID | GO:0070290 |
|---|---|
| GO term | N-acylphosphatidylethanolamine-specific phospholipase D activity |
| Ontology | molecular_function |
| Synonym | N-acyl-phosphatidylethanolamine-specific phospholipase D activity; NAPE-specific phospholipase D activity |
| Major function | Hydrolysis of NAPE to NAE and phosphatidic acid, generating endocannabinoid-related lipid mediators |
| Representative enzyme | NAPE-PLD (N-acylphosphatidylethanolamine phospholipase D) |
| Key tissues | Macrophages, endometrium, placenta, adipose tissue |
| Disease links | Endometrial carcinoma, inflammation, pregnancy disorders |
What Is GO:0070290?
GO:0070290 is defined as the catalysis of the reaction: an N-acyl-1,2-diacyl-sn-glycero-3-phosphoethanolamine (NAPE) + H2O = an N-acylethanolamine (NAE) + a 1,2-diacyl-sn-glycero-3-phosphate + H+. In simpler terms, it is a phospholipase D-type activity that cleaves NAPE to release an NAE signaling lipid and phosphatidic acid. The term is synonymous with NAPE-specific phospholipase D activity and is classified under molecular_function in the Gene Ontology.
Why Is N-acylphosphatidylethanolamine-specific phospholipase D activity Important in Cell Biology?
GO:0070290 is important because it produces N-acylethanolamines, a family of lipid signaling molecules that include anandamide and other endocannabinoid-like mediators. These lipids regulate inflammation, pain, appetite, and reproductive biology, and their dysregulation is implicated in cancer, metabolic disease, and pregnancy complications. Understanding this activity at the molecular level enables researchers to design targeted interventions and to interpret how lipid signaling contributes to disease.
• Generates N-acylethanolamines, including anandamide, which are key endocannabinoid-related signaling lipids.
• Links phospholipid metabolism to the endocannabinoid system, influencing pain and inflammation.
• Is induced by proinflammatory stimuli in macrophages, connecting it to innate immunity.
• Plays a role in uterine and placental biology, affecting embryo implantation and pregnancy maintenance.
• Is dysregulated in endometrial carcinoma, suggesting a role in cancer biology.
• Modulates adipocyte biology, with potential implications for metabolic disorders.
• Provides a druggable node for modulating endocannabinoid tone in disease.
• Serves as a model for studying phospholipase D-type catalytic mechanisms.
• Enables CRISPR-based functional studies of lipid signaling in health and disease.
Molecular Mechanism of N-acylphosphatidylethanolamine-specific phospholipase D activity
Substrate recognition and binding
In simple terms: The enzyme must first grab its lipid substrate, NAPE, from the membrane.
NAPE-PLD recognizes N-acylphosphatidylethanolamine (NAPE) as its substrate, a membrane phospholipid with an N-acyl chain. The enzyme binds NAPE and positions it for hydrolysis, a step that is essential for generating N-acylethanolamines. This substrate specificity distinguishes GO:0070290 from other phospholipase activities.
Catalytic hydrolysis
In simple terms: The enzyme cuts NAPE into two products: an NAE and phosphatidic acid.
The catalytic reaction of GO:0070290 is a phospholipase D-type hydrolysis: NAPE + H2O = NAE + phosphatidic acid + H+. This cleavage releases the N-acylethanolamine headgroup, which can act as a signaling lipid, and phosphatidic acid, which itself has signaling roles. The reaction is central to endocannabinoid biosynthesis because it provides a direct route to NAE production.
Product release and signaling
In simple terms: The products leave the enzyme and go on to send signals in the cell.
After catalysis, the NAE product can be released from the membrane and act on targets such as cannabinoid receptors or other lipid-sensing pathways. Phosphatidic acid may remain in the membrane or be converted to other lipids, contributing to lipid signaling networks. The balance between NAE production and degradation shapes endocannabinoid tone in tissues such as the uterus and placenta.
Regulation by inflammatory and hormonal cues
In simple terms: The activity of this enzyme can go up or down depending on signals like inflammation or hormones.
Proinflammatory stimuli such as lipopolysaccharide increase NAPE-PLD expression in macrophages, linking GO:0070290 to immune activation. In reproductive tissues, hormonal changes during the estrous cycle and early pregnancy modulate NAPE-PLD expression and activity, affecting endocannabinoid levels. These regulatory inputs allow the enzyme to adjust lipid signaling in response to physiological demands.
Key Genes Involved in GO:0070290 N-acylphosphatidylethanolamine-specific phospholipase D activity
The following genes and proteins are directly or functionally associated with GO:0070290 and its biological roles.
| Gene | Major Role | Research Relevance |
|---|---|---|
| NAPE-PLD (NAPEPLD) | Primary enzyme catalyzing GO:0070290 | Target for knockout and overexpression studies in lipid signaling |
| FAAH | Degrades N-acylethanolamines such as anandamide | Modulates endocannabinoid tone alongside NAPE-PLD |
| CB1 (CNR1) | Cannabinoid receptor mediating NAE effects | Downstream effector of NAPE-PLD products |
| CB2 (CNR2) | Cannabinoid receptor in immune cells | Links NAPE-PLD activity to inflammation |
| GPR55 | Lipid-sensing receptor | Potential mediator of NAPE-PLD-derived lipids |
| PPAR-alpha (PPARA) | Nuclear receptor activated by NAE lipids | Mediates metabolic effects of NAPE-PLD products |
| PPAR-gamma (PPARG) | Nuclear receptor involved in adipocyte biology | Linked to NAPE-PLD modulation in adipose tissue |
| TRPV1 | Ion channel activated by anandamide | Downstream target of NAPE-PLD-generated NAE |
| COX-2 (PTGS2) | Prostaglandin synthase, inflammation | Interacts with endocannabinoid pathways in uterus |
| PLA2G4A | Phospholipase A2, arachidonic acid release | Cross-talk with NAPE-PLD in lipid mediator production |
| ABHD4 | Alternative NAE-producing enzyme | Compensatory pathway for NAPE-PLD |
| GDE1 | Alternative NAE-producing enzyme | Potential redundancy with NAPE-PLD |
| PLD2 | Phospholipase D family member | Related phospholipase D activity for comparison |
| PTPN22 | Immune signaling regulator | Modulates inflammatory responses linked to NAPE-PLD |
| NF-kB (RELA) | Transcription factor driving inflammation | Regulates NAPE-PLD expression in macrophages |
| ESR1 | Estrogen receptor | Hormonal regulation of NAPE-PLD in reproductive tissues |
| PGR | Progesterone receptor | Influences NAPE-PLD during pregnancy |
| LPS (bacterial component) | Proinflammatory stimulus | Induces NAPE-PLD expression in macrophages |
How Is N-acylphosphatidylethanolamine-specific phospholipase D activity Regulated?
NAPE-PLD expression and activity are regulated by proinflammatory stimuli such as lipopolysaccharide in macrophages, which increases NAPE-PLD levels and links GO:0070290 to innate immune responses. In reproductive tissues, hormonal fluctuations during the estrous cycle and early pregnancy modulate NAPE-PLD expression, affecting endocannabinoid tone. The enzyme's activity can also be influenced by the availability of its NAPE substrate and by competing NAE-producing pathways such as ABHD4 and GDE1. These regulatory layers ensure that NAE production is tuned to physiological context.
N-acylphosphatidylethanolamine-specific phospholipase D activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| NAPEPLD | Endometrial carcinoma | Knockout and overexpression in endometrial cancer cell lines |
| NAPEPLD | Preterm labor / pregnancy disorders | LPS-induced preterm labor mouse model with Napepld knockout |
| NAPEPLD | Inflammation | Macrophage-specific knockout and overexpression |
| FAAH | Endocannabinoid-related disorders | Double knockout with Napepld to assess pathway redundancy |
| CNR1 | Metabolic and reproductive disorders | Conditional knockout in adipose or uterine tissue |
Endometrial carcinoma
NAPE-PLD expression is altered in endometrial carcinoma, and the enzyme is proposed to influence tumor biology through endocannabinoid signaling. The balance between NAPE-PLD and FAAH may affect NAE levels that modulate cancer cell proliferation and survival.
Pregnancy disorders and preterm labor
The endocannabinoid system, including NAPE-PLD, plays a role in uterine function and placental development, and its dysregulation has been implicated in preterm labor and other pregnancy complications. LPS-induced preterm labor models show changes in endocannabinoid-related enzymes, suggesting that NAPE-PLD activity contributes to inflammatory pathways in parturition.
Inflammation and metabolic disease
Proinflammatory stimuli induce NAPE-PLD in macrophages, linking GO:0070290 to chronic inflammatory conditions. In adipose tissue, modulation of the endocannabinoid system affects adipocyte biology, suggesting that NAPE-PLD may influence metabolic disease.
From N-acylphosphatidylethanolamine-specific phospholipase D activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does NAPE-PLD loss alter NAE levels? | NAPE-PLD knockout cell line or mouse |
| Does a specific point mutation affect catalytic activity? | Point-mutation knock-in of NAPEPLD |
| Can a tagged NAPE-PLD be used for localization studies? | Tagged knock-in (e.g., GFP or FLAG) |
| Does NAPE-PLD overexpression change lipid signaling? | Overexpression in cell lines or transgenic models |
| Which genes compensate for NAPE-PLD loss? | CRISPR library screening in knockout background |
| How does NAPE-PLD affect tumor growth? | Xenograft models with knockout or overexpression |
How to Study the N-acylphosphatidylethanolamine-specific phospholipase D activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Lipidomics (LC-MS/MS) | NAE and phosphatidic acid levels | Quantifying GO:0070290 products in cells |
| Enzyme activity assay | Phospholipase D hydrolysis of NAPE | Direct measurement of catalytic activity |
| qPCR | NAPEPLD mRNA expression | Response to LPS or hormones |
| RNA-seq | Transcriptome changes | Pathway analysis in knockout models |
| Western blot | NAPE-PLD protein levels | Validation of expression changes |
| Immunofluorescence | Subcellular localization | Membrane association studies |
| CRISPR knockout | Loss-of-function phenotype | Causal testing in disease models |
| CRISPR knock-in | Tagged or mutant NAPE-PLD | Localization and catalytic studies |
Lipidomics and mass spectrometry
Mass spectrometry-based lipidomics can quantify NAE and phosphatidic acid levels to measure GO:0070290 activity in cells and tissues. This approach is essential for linking enzyme expression to product formation.
Enzymatic activity assays
In vitro assays using radiolabeled or fluorescent NAPE substrates can directly measure phospholipase D activity. These assays help distinguish NAPE-PLD from other NAE-producing enzymes.
Gene expression analysis
Quantitative PCR and RNA-seq can measure NAPEPLD mRNA levels in response to stimuli such as LPS or hormonal changes. This is useful for understanding transcriptional regulation of GO:0070290.
CRISPR-based functional genomics
Knockout, knock-in, and point-mutation models allow researchers to test the causal role of NAPE-PLD in disease phenotypes. Library screening can identify modifiers of NAE production.
How CRISPR Can Be Used to Study GO:0070290 N-acylphosphatidylethanolamine-specific phospholipase D activity
Knockout
CRISPR knockout of NAPEPLD eliminates GO:0070290 activity, allowing researchers to measure changes in NAE levels and downstream phenotypes. Knockout models are valuable for studying inflammation, reproduction, and cancer.
Point Mutation
Point mutations can be introduced into the NAPEPLD catalytic domain to dissect residues required for substrate binding and hydrolysis. Such models help distinguish catalytic activity from scaffolding functions.
Knock-in
Knock-in of epitope-tagged NAPE-PLD enables localization and interaction studies without altering endogenous regulation. This approach is useful for tracking the enzyme in live cells.
Overexpression
Overexpression of NAPE-PLD increases GO:0070290 activity and can elevate NAE production, providing a gain-of-function system to study lipid signaling. This is particularly useful in adipocyte and cancer models.
How EDITGENE Supports N-acylphosphatidylethanolamine-specific phospholipase D activity Research
Researchers studying N-acylphosphatidylethanolamine-specific phospholipase D activity-related genes often need to determine whether a candidate gene is causally involved in lipid signaling, inflammation, or disease. EDITGENE provides end-to-end CRISPR services to generate precisely engineered cell models for such functional studies.
Contact EDITGENE today to design your custom CRISPR model for N-acylphosphatidylethanolamine-specific phospholipase D activity research.
Frequently Asked Questions About N-acylphosphatidylethanolamine-specific phospholipase D activity
What is GO:0070290?
GO:0070290 is the Gene Ontology term for N-acylphosphatidylethanolamine-specific phospholipase D activity, an enzyme activity that converts NAPE to NAE and phosphatidic acid.
What does NAPE-PLD do?
NAPE-PLD catalyzes the hydrolysis of N-acylphosphatidylethanolamine to release N-acylethanolamines, which are endocannabinoid-related signaling lipids.
What genes are involved in N-acylphosphatidylethanolamine-specific phospholipase D activity?
The primary gene is NAPEPLD, which encodes NAPE-PLD; related genes include FAAH, CNR1, CNR2, and ABHD4.
Which diseases are linked to NAPE-PLD?
NAPE-PLD has been linked to endometrial carcinoma, inflammation, and pregnancy disorders such as preterm labor.
How is NAPE-PLD regulated?
NAPE-PLD expression is induced by proinflammatory stimuli like LPS and modulated by hormonal changes in reproductive tissues.
What is the reaction catalyzed by GO:0070290?
The reaction is NAPE + H2O = NAE + phosphatidic acid + H+, a phospholipase D-type hydrolysis.
Why is NAPE-PLD important in the endocannabinoid system?
It produces N-acylethanolamines such as anandamide, which act on cannabinoid receptors and other targets to modulate pain, inflammation, and reproduction.
Can CRISPR be used to study NAPE-PLD?
Yes, CRISPR knockout, knock-in, point-mutation, and overexpression models are widely used to study NAPE-PLD function.
What tissues express NAPE-PLD?
NAPE-PLD is expressed in macrophages, endometrium, placenta, and adipose tissue, among other tissues.
How can I measure NAPE-PLD activity?
Activity can be measured using lipidomics to quantify NAE products or direct enzymatic assays with NAPE substrates.
Conclusion
GO:0070290, N-acylphosphatidylethanolamine-specific phospholipase D activity, is a central enzymatic step in endocannabinoid-related lipid signaling. Its product N-acylethanolamines influence inflammation, reproduction, and metabolism, and dysregulation of NAPE-PLD is implicated in cancer and pregnancy disorders. Continued research using CRISPR-based models and lipidomics will clarify how this activity can be targeted therapeutically.
References
- 1. Zhu C et al.. 2011. Proinflammatory stimuli control N-acylphosphatidylethanolamine-specific phospholipase D expression in macrophages.. Mol Pharmacol 79(4):786-92 PMID: 21233218
- 2. Ayakannu T et al.. 2019. Expression and Function of the Endocannabinoid Modulating Enzymes Fatty Acid Amide Hydrolase and N-Acylphosphatidylethanolamine-Specific Phospholipase D in Endometrial Carcinoma.. Front Oncol 9:1363 PMID: 31921630
- 3. Hanske A et al.. 2026. Chemical Probes for Investigating the Endocannabinoid System.. Curr Top Behav Neurosci 76:69-144 PMID: 39747798
- 4. Maia J et al.. 2020. The fundamental role of the endocannabinoid system in endometrium and placenta: implications in pathophysiological aspects of uterine and pregnancy disorders.. Hum Reprod Update 26(4):586-602 PMID: 32347309
- 5. Teixeira D et al.. 2010. Modulation of adipocyte biology by δ(9)-tetrahydrocannabinol.. Obesity (Silver Spring) 18(11):2077-85 PMID: 20467421
- 6. Bari M et al.. 2006. New insights into endocannabinoid degradation and its therapeutic potential.. Mini Rev Med Chem 6(3):257-68 PMID: 16515464
- 7. Bariani MV et al.. 2015. Role of the endocannabinoid system in the mechanisms involved in the LPS-induced preterm labor.. Reproduction 150(6):463-72 PMID: 26347521
- 8. Wang H et al.. 2007. Differential regulation of endocannabinoid synthesis and degradation in the uterus during embryo implantation.. Prostaglandins Other Lipid Mediat 83(1-2):62-74 PMID: 17259073
